Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder affecting
approximately 1 in 20,000 people. Patients typically present with clinically benign …

Immune thrombocytopenia (ITP) is an autoimmune process resulting in increased
destruction and inadequate production of platelets that can result in bleeding, fatigue, and …

Immune thrombocytopenia (ITP) comprises a heterogeneous group of disorders
characterized by autoimmune-mediated platelet destruction and impairment of …

Immune thrombocytopenia (ITP) comprises a syndrome of diverse disorders that have in
common immune‐mediated thrombocytopenia, but that differ with respect to pathogenesis …

Immune thrombocytopenia (ITP) is an acquired hemorrhagic condition characterized by the
accelerated clearance of platelets caused by antiplatelet autoantibodies. A platelet count in …

Key Clinical Points Immune Thrombocytopenia Immune thrombocytopenia (ITP) is
diagnosed in patients with a platelet count below 100,000 per cubic millimeter in whom …

Immune thrombocytopenia (ITP) occurs in 2 to 4/100 000 adults and results in variable
bleeding symptoms and thrombocytopenia. In the last decade, changes in our …

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by platelet
destruction and reduced platelet production resulting in decreased platelet level and an …

Very few data exist on the management of adult patients diagnosed with primary immune
thrombocytopenia (ITP). The objectives of this study were to describe the diagnostic and …

Primary immune thrombocytopenia (ITP) is an immune-mediated bleeding disorder
characterized by decreased platelet counts and an increased risk of bleeding. Multiple …